XML 52 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Information
 6 Months Ended
Sep. 28, 2012
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
UNAUDITED CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The 2012 Notes of the Company (the “Parent”) are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of its domestic subsidiaries (the “Guarantor Subsidiaries”). The guarantees made by the Guarantor Subsidiaries will rank senior in right of payment to all of their existing and future obligations expressly subordinated or junior in right of payment to the notes, equal with all of their existing and future unsecured unsubordinated obligations, and will be effectively subordinated to any of their existing and future secured obligations to the extent of the value of the assets securing such obligations.

The following tables present the condensed consolidating financial information of the Parent, the Guarantor Subsidiaries, and the subsidiaries that are not guarantors (the “Non-Guarantor Subsidiaries”) as of September 28, 2012 and March 30, 2012 and for the years ended September 28, 2012 and September 30, 2011.

 

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET
SEPTEMBER 28, 2012
(Dollars in Thousands)

  Parent Guarantor Subsidiaries  Non-Guarantor Subsidiaries Eliminations Consolidated
ASSETS                
Current Assets:                
 Cash and cash equivalents $ 47,515 $ 18,087  $ 56,749 $ - $ 122,351
 Accounts receivable, net    133,691   60,564    -   -   194,255
 Inventories   120,559   44,813    257   -   165,629
 Intercompany receivable (payable)   369,087   (337,760)    (23,111)   (8,216)   -
 Prepaid expenses and other current assets   47,374   4,647    703   -   52,724
 Assets held for sale   27,911   253,886    2,080   (2,714)   281,163
  Total current assets    746,137   44,237    36,678   (10,930)   816,122
Property and equipment, net    38,427   45,491    90   -   84,008
Other Assets:                
 Goodwill    33,101   109,372    -   -   142,473
 Intangibles, net   9,883   42,919    -   -   52,802
 Investment in subsidiaries   169,019   32,846    -   (201,865)   -
 Other assets   100,202   16,326    36   -   116,564
  Total assets $ 1,096,769 $ 291,191  $ 36,804 $ (212,795) $ 1,211,969
                   
LIABILITIES AND EQUITY                
Current Liabilities:                
 Accounts payable  $ 107,440 $ 24,201  $ 430 $ - $ 132,071
 Accrued expenses    17,455   18,596    45   -   36,096
 Other current liabilities   1,957   10,692    (14)   -   12,635
 Liabilities held for sale   5,468   43,214    3,308   (4,804)   47,186
  Total current liabilities    132,320   96,703    3,769   (4,804)   227,988
                   
Revolving line of credit and long-term debt, excluding current portion    459,845   -    -   -   459,845
Other noncurrent liabilities    93,405   19,532    -   -   112,937
  Total liabilities   685,570   116,235    3,769   (4,804)   800,770
Equity:                
 PSS World Medical Inc. shareholders' equity:                
  Total PSS World Medical, Inc. shareholders' equity   411,199   174,406    33,035   (211,040)   407,600
 Noncontrolling interest   -   550    -   3,049   3,599
  Total equity   411,199   174,956    33,035   (207,991)   411,199
  Total liabilities and equity  $ 1,096,769 $ 291,191  $ 36,804 $ (212,795) $ 1,211,969

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET
MARCH 30, 2012
(Dollars in Thousands)

 Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
ASSETS              
Current Assets:              
 Cash and cash equivalents$ 117,448 $ 13,529 $ 32,175 $ - $ 163,152
 Accounts receivable, net   137,214   22,591   29,737   -   189,542
 Inventories  113,635   33,310   253   -   147,198
 Intercompany receivable (payable)  290,404   (253,925)   (37,043)   564   -
 Prepaid expenses and other current assets  39,483   4,590   113   -   44,186
 Assets held for sale  26,975   250,522   2,526   (2,645)   277,378
  Total current assets   725,159   70,617   27,761   (2,081)   821,456
Property and equipment, net   39,854   40,189   108   -   80,151
Other Assets:              
 Goodwill   31,319   78,138   -   -   109,457
 Intangibles, net  10,435   23,111   -   -   33,546
 Investment in subsidiaries  184,218   23,942   -   (208,160)   -
 Other assets  95,951   15,373   36   -   111,360
  Total assets$ 1,086,936 $ 251,370 $ 27,905 $ (210,241) $ 1,155,970
                 
LIABILITIES AND EQUITY              
Current Liabilities:              
 Accounts payable $ 122,254 $ (4,121) $ 586 $ - $ 118,719
 Accrued expenses   20,211   17,176   49   -   37,436
 Other current liabilities  2,667   5,348   -   -   8,015
 Liabilities held for sale  4,025   36,456   3,095   (5,936)   37,640
  Total current liabilities   149,157   54,859   3,730   (5,936)   201,810
                 
Revolving line of credit and long-term debt, excluding current portion   454,916   -   -   -   454,916
Other noncurrent liabilities   92,052   16,381   -   -   108,433
  Total liabilities  696,125   71,240   3,730   (5,936)   765,159
Equity:              
 PSS World Medical Inc. shareholders' equity:              
  Total PSS World Medical, Inc. shareholders' equity  390,811   179,536   24,175   (207,394)   387,128
 Noncontrolling interest  -   594   -   3,089   3,683
  Total equity  390,811   180,130   24,175   (204,305)   390,811
  Total liabilities and equity $ 1,086,936 $ 251,370 $ 27,905 $ (210,241) $ 1,155,970

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
FOR THE THREE MONTHS ENDED SEPTEMBER 28, 2012
(Dollars in Thousands)

    Parent Guarantor Subsidiaries  Non-Guarantor Subsidiaries Eliminations Consolidated
Net sales $ 298,495 $ 120,368  $ 30,331 $ (28,396) $ 420,798
Cost of goods sold   209,910   67,339    23,629   (22,256)   278,622
  Gross profit  88,585   53,029    6,702   (6,140)   142,176
General and administrative expenses  51,038   26,073    1,159   -   78,270
Selling expenses   27,254   9,681    -   -   36,935
Equity earnings of subsidiaries  10,490   5,584    -   (16,074)   -
  Income from operations   20,783   22,859    5,543   (22,214)   26,971
Other income (expense):               
 Interest expense   (8,531)   (7)    -   -   (8,538)
 Interest income  351   (338)    -   -   13
 Other income, net   83   161    (1)   -   243
  Other expense, net  (8,097)   (184)    (1)   -   (8,282)
Income from continuing operations before provision for income taxes   12,686   22,675    5,542   (22,214)   18,689
(Benefit) provision for income taxes   (7,694)   13,590    -   -   5,896
Income from continuing operations  20,380   9,085    5,542   (22,214)   12,793
Income from discontinued operations, net of taxes  1,152   1,405    42   5   2,604
                   
Net income  21,532   10,490    5,584   (22,209)   15,397
Net (loss) income attributable to noncontrolling interest  -   (29)    -   156   127
Net income attributable to PSS World Medical, Inc.$ 21,532 $ 10,519  $ 5,584 $ (22,365) $ 15,270

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2011
(Dollars in Thousands)

    Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
Net sales $ 293,019 $ 95,681 $ 3,010 $ - $ 391,710
Cost of goods sold   208,033   53,129   622   -   261,784
  Gross profit  84,986   42,552   2,388   -   129,926
General and administrative expenses  47,286   19,394   983   -   67,663
Selling expenses   25,130   7,089   -   -   32,219
Equity earnings of subsidiaries  7,184   1,483   -   (8,667)   -
  Income from operations   19,754   17,552   1,405   (8,667)   30,044
Other income (expense):              
 Interest expense   (4,483)   (128)   -   -   (4,611)
 Interest income   324   (307)   -   -   17
 Other income, net   295   146   (4)   -   437
  Other expense, net  (3,864)   (289)   (4)   -   (4,157)
Income from continuing operations before provision for income taxes   15,890   17,263   1,401   (8,667)   25,887
(Benefit) provision for income taxes   (3,272)   12,812   -   -   9,540
Income from continuing operations  19,162   4,451   1,401   (8,667)   16,347
Income from discontinued operations, net of taxes  958   2,733   82   5   3,778
                  
Net income  20,120   7,184   1,483   (8,662)   20,125
Net income attributable to noncontrolling interest  -   84   -   10   94
Net income attributable to PSS World Medical, Inc.$ 20,120 $ 7,100 $ 1,483 $ (8,672) $ 20,031

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
FOR THE SIX MONTHS ENDED SEPTEMBER 28, 2012
(Dollars in Thousands)

    Parent Guarantor Subsidiaries  Non-Guarantor Subsidiaries Eliminations Consolidated
Net sales $ 596,655 $ 220,580  $ 53,475 $ (40,523) $ 830,187
Cost of goods sold   421,217   118,713    42,323   (30,531)   551,722
  Gross profit  175,438   101,867    11,152   (9,992)   278,465
General and administrative expenses  105,331   50,347    2,274   -   157,952
Selling expenses   53,711   18,577    -   -   72,288
Equity earnings of subsidiaries  16,452   8,860    -   (25,312)   -
  Income from operations   32,848   41,803    8,878   (35,304)   48,225
Other income (expense):               
 Interest expense   (17,024)   (18)    -   -   (17,042)
 Interest income  705   (678)    -   -   27
 Other income, net   378   347    (2)   -   723
  Other expense, net  (15,941)   (349)    (2)   -   (16,292)
Income from continuing operations before provision for income taxes   16,907   41,454    8,876   (35,304)   31,933
(Benefit) provision for income taxes   (16,698)   26,992    -   -   10,294
Income from continuing operations  33,605   14,462    8,876   (35,304)   21,639
Income (loss) from discontinued operations, net of taxes  2,307   1,990    (16)   10   4,291
                   
Net income  35,912   16,452    8,860   (35,294)   25,930
Net loss attributable to noncontrolling interest  -   (44)    -   (40)   (84)
Net income attributable to PSS World Medical, Inc.$ 35,912 $ 16,496  $ 8,860 $ (35,254) $ 26,014

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2011
(Dollars in Thousands)

    Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
Net sales $ 579,863 $ 185,977 $ 6,361 $ - $ 772,201
Cost of goods sold   413,832   104,537   1,232   -   519,601
  Gross profit  166,031   81,440   5,129   -   252,600
General and administrative expenses  98,259   39,444   1,908   -   139,611
Selling expenses   48,967   14,012   -   -   62,979
Equity earnings of subsidiaries  11,194   3,347   -   (14,541)   -
  Income from operations   29,999   31,331   3,221   (14,541)   50,010
Other income (expense):              
 Interest expense   (8,807)   (274)   -   -   (9,081)
 Interest income   667   (623)   -   -   44
 Other income, net   608   373   (12)   -   969
  Other expense, net  (7,532)   (524)   (12)   -   (8,068)
Income from continuing operations before provision for income taxes   22,467   30,807   3,209   (14,541)   41,942
(Benefit) provision for income taxes   (9,716)   25,155   -   -   15,439
Income from continuing operations  32,183   5,652   3,209   (14,541)   26,503
Income from discontinued operations, net of taxes  2,077   5,542   138   10   7,767
                  
Net income  34,260   11,194   3,347   (14,531)   34,270
Net loss attributable to noncontrolling interest  -   55   -   (6)   49
Net income attributable to PSS World Medical, Inc.$ 34,260 $ 11,139 $ 3,347 $ (14,525) $ 34,221

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED SEPTEMBER 28, 2012
(Dollars in Thousands)

    Parent Guarantor Subsidiaries  Non-Guarantor Subsidiaries Eliminations Consolidated
Cash Flows From Operating Activities:               
   Net cash (used in) provided by operating activities$ (79,189) $ 103,101  $ 24,472 $ 78 $ 48,462
Cash Flows From Investing Activities:               
 Payments for business combinations, net of cash acquired  (2,509)   (66,229)    -   -   (68,738)
 Capital expenditures  (1,749)   (9,284)    (1)   -   (11,034)
 Other  (28)   (142)    -   -   (170)
 Net cash used in investing activities, discontinued operations  (37)   (1,218)    25   -   (1,230)
   Net cash used in investing activities  (4,323)   (76,873)    24   -   (81,172)
Cash Flows From Financing Activities:               
 Purchase and retirement of common stock  (7,740)   -    -   -   (7,740)
 Excess tax benefits from stock-based compensation arrangements  315   -    -   -   315
 Payment for debt issuance costs  (676)   -    -   -   (676)
 Proceeds from exercise of stock options  10   -    -   -   10
 Intercompany dividend  21,670   (21,670)    -   -   -
 Net cash (used in) provided by financing activities, discontinued operations  -   -    78   (78)   -
   Net cash provided by (used in) financing activities  13,579   (21,670)    78   (78)   (8,091)
                   
 Net (decrease) increase in cash and cash equivalents  (69,933)   4,558    24,574   -   (40,801)
 Cash and cash equivalents, beginning of period  117,448   13,529    32,175   -   163,152
 Cash and cash equivalents, end of period$ 47,515 $ 18,087  $ 56,749 $ - $ 122,351

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2011
(Dollars in Thousands)

    Parent Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
Cash Flows From Operating Activities:              
   Net cash provided by (used in) operating activities$ 12,283 $ 45,018 $ 148 $ 34 $ 57,483
Cash Flows From Investing Activities:              
 Payments for business combinations, net of cash acquired  (334)   (9,702)   -   -   (10,036)
 Capital expenditures  (1,458)   (8,227)   (3)   -   (9,688)
 Other  (48)   -   -   -   (48)
 Net cash used in investing activities, discontinued operations  (23)   (1,476)   (31)   -   (1,530)
   Net cash used in investing activities  (1,863)   (19,405)   (34)   -   (21,302)
Cash Flows From Financing Activities:              
 Purchase and retirement of common stock  (80,905)   -   -   -   (80,905)
 Excess tax benefits from stock-based compensation arrangements  1,269   -   -   -   1,269
 Proceeds from exercise of stock options  337   -   -   -   337
 Proceeds from borrowings on the revolving line of credit  131,583   -   -   -   131,583
 Repayments on the revolving line of credit  (81,583)   -   -   -   (81,583)
 Payment of contingent consideration on business acquisitions  -   (1,000)   -   -   (1,000)
 Payments under capital lease obligations  (18)   (342)   -   -   (360)
 Intercompany dividend  19,200   (19,200)   -   -   -
 Net cash used in financing activities, discontinued operations  -   (22)   34   (34)   (22)
   Net cash (used in) provided by financing activities  (10,117)   (20,564)   34   (34)   (30,681)
                  
 Net (decrease) increase in cash and cash equivalents  303   5,049   148   -   5,500
 Cash and cash equivalents, beginning of period  13,901   3,568   11,879   -   29,348
 Cash and cash equivalents, end of period$ 14,204 $ 8,617 $ 12,027 $ - $ 34,848